The Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis Offers Efficient Bystander Cell Killing for Suicide Gene Therapy of Cancer

समान संसाधन

• Transgenic cardiac targeted overexpression of human thymidylate kinase (TMPK)
  द्वारा: Kohler, James J., और अन्य
  प्रकाशित: (2010)
• Restoration of the antiviral activity of 3′-azido-3′-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus by delivery of engineered thymidylate kinase to T cells
  द्वारा: Lavie, Arnon, और अन्य
  प्रकाशित: (2008)
• Cell Fate Control Gene Therapy Based on Engineered Variants of Human Deoxycytidine Kinase
  द्वारा: Neschadim, Anton, और अन्य
  प्रकाशित: (2012)
• Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics
  द्वारा: Zweiri, Jehad, और अन्य
  प्रकाशित: (2020)
• Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug
  द्वारा: Cheng, T L, और अन्य
  प्रकाशित: (1999)